ArticleHematology. American Society of Hematology. Education Program2023

How to classify risk based on clinical and molecular modeling: integrating molecular markers in the risk assessment of myelodysplastic syndrome.

Rena R XianPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.